The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vilches, C.
Right arrow Articles by Parham, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vilches, C.
Right arrow Articles by Parham, P.
The Journal of Immunology, 2000, 165: 6416-6421.
Copyright © 2000 by The American Association of Immunologists

Gene Structure and Promoter Variation of Expressed and Nonexpressed Variants of the KIR2DL5 Gene1 ,2

Carlos Vilches3, Clair M. Gardiner and Peter Parham4

Departments of Structural Biology and Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305

Two variants of the novel KIR2DL5 gene (KIR2DL5.1 and .2) were identified in genomic DNA of a single donor. However, only the KIR2DL5.1 variant was transcribed in PBMC. In this study, analysis of seven additional donors reveals two new variants of the KIR2DL5 gene and indicates that transcription, or its lack, are consistently associated with particular variants of this gene. Comparison of the complete nucleotide sequences of the exons and introns of KIR2DL5.1 and KIR2DL5.2 reveals no structural abnormalities, but similar open reading frames for both variants. In contrast, the promoter region of KIR2DL5 shows a high degree of sequence polymorphism that is likely relevant for expression. Substitution within a putative binding site for the transcription factor acute myeloid leukemia gene 1 could determine the lack of expression for some KIR2DL5 variants.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
A. Iannello, O. Debbeche, S. Samarani, and A. Ahmad
Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS
J. Leukoc. Biol., July 1, 2008; 84(1): 1 - 26.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Estefania, R. Flores, N. Gomez-Lozano, H. Aguilar, M. Lopez-Botet, and C. Vilches
Human KIR2DL5 Is an Inhibitory Receptor Expressed on the Surface of NK and T Lymphocyte Subsets
J. Immunol., April 1, 2007; 178(7): 4402 - 4410.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. J. VandenBussche, S. Dakshanamurthy, P. E. Posch, and C. K. Hurley
A Single Polymorphism Disrupts the Killer Ig-Like Receptor 2DL2/2DL3 D1 Domain
J. Immunol., October 15, 2006; 177(8): 5347 - 5357.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. Yawata, N. Yawata, M. Draghi, A.-M. Little, F. Partheniou, and P. Parham
Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function
J. Exp. Med., March 20, 2006; 203(3): 633 - 645.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Xu, A. N. Vallejo, Y. Jiang, C. M. Weyand, and J. J. Goronzy
Distinct Transcriptional Control Mechanisms of Killer Immunoglobulin-like Receptors in Natural Killer (NK) and in T Cells
J. Biol. Chem., June 24, 2005; 280(25): 24277 - 24285.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S.-i. Yusa, T. L. Catina, and K. S. Campbell
KIR2DL5 Can Inhibit Human NK Cell Activation Via Recruitment of Src Homology Region 2-Containing Protein Tyrosine Phosphatase-2 (SHP-2)
J. Immunol., June 15, 2004; 172(12): 7385 - 7392.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. P. Martin, A. Bashirova, J. Traherne, J. Trowsdale, and M. Carrington
Cutting Edge: Expansion of the KIR Locus by Unequal Crossing Over
J. Immunol., September 1, 2003; 171(5): 2192 - 2195.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. A. Stewart, J. van Bergen, and J. Trowsdale
Different and Divergent Regulation of the KIR2DL4 and KIR3DL1 Promoters
J. Immunol., June 15, 2003; 170(12): 6073 - 6081.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. C. Hsu, X.-R. Liu, A. Selvakumar, E. Mickelson, R. J. O'Reilly, and B. Dupont
Killer Ig-Like Receptor Haplotype Analysis by Gene Content: Evidence for Genomic Diversity with a Minimum of Six Basic Framework Haplotypes, Each with Multiple Subsets
J. Immunol., November 1, 2002; 169(9): 5118 - 5129.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Santourlidis, H.-I. Trompeter, S. Weinhold, B. Eisermann, K. L. Meyer, P. Wernet, and M. Uhrberg
Crucial Role of DNA Methylation in Determination of Clonally Distributed Killer Cell Ig-like Receptor Expression Patterns in NK Cells
J. Immunol., October 15, 2002; 169(8): 4253 - 4261.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. M. Gardiner, L. A. Guethlein, H. G. Shilling, M. Pando, W. H. Carr, R. Rajalingam, C. Vilches, and P. Parham
Different NK Cell Surface Phenotypes Defined by the DX9 Antibody Are Due to KIR3DL1 Gene Polymorphism
J. Immunol., March 1, 2001; 166(5): 2992 - 3001.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.